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B lymphocytes must interact with T  cells for most immune responses. Some of these 
interactions, however, can be mediated by soluble products. Thus, supernatants of T 
cells stimulated in mixed lymphocyte reaction (MLR) (1, 2) or by polyclonal activators 
like coneanavalin A  (Con A)  (3) can replace T  cells in an in vitro immune response. 
This activity was attributed to a single entity and was given the name T  cell-replacing 
factor (TRF). Reports that antigen alone induces B cell proliferation (4, 5) and TRF 
functions when added  after B  cell exposure to antigen  (2)  led to a  model in which 
nonspecific TRF induces antibody secretion by acting on B cells already proliferating 
in response to antigen  (5, 6). 
Subsequent experiments have suggested a more complex model. Purified interleukin 
2  (IL-2),  a  T  cell  growth  factor  (7),  restores  in  vitro  immune  responses  to  sheep 
erythrocyte  (SRBC)  antigens  in  cultures  of nude  (8)  and  normal  (9)  spleen  cells 
pretreated with anti-Thy-1 or anti-theta and complement. With more rigorous T  cell 
depletion, however, IL-2 no longer replaces T  cells (9,  10), and a second T  cell activity 
is  needed  to synergize with  IL-2 to restore in  vitro B  cell  antibody secretion.  One 
source of this TRF activity, (DL)TRF, is the monoclonal Dennert alloreactive T  celt 
line C.C3.11.75  (10). A similar activity has been described in the 30,000-40,000  mol 
wt fraction of Con A supernatants  (11). 
There are  thus  at  least  two  component  activities  in  the  earlier  TRF.  It  is  now 
necessary to redefine the role and target cell of each. B cell preparations obtained by 
anti-thymocyte  serum  (ATS)  preinjection  and  treatment  with  several  anti-T  cell 
reagents may still contain small numbers of T  cells or their precursors, which mature 
during culture  (12).  Hence, IL-2 or (DL)TRF may act on residual T  cells to restore 
immunocompetence of conventional T  cell-depleted B cell preparations. Only in the 
complete absence of T cell function can unequivocal description of a mediator's target 
cell be made. 
We used a  B cell cloning system, described by Wetzel and Kettman (13), in which 
the  response  of  a  single  isolated  B  cell  can  be  followed.  (DL)TRF  containing 
supernatants  increased  the proportion  of B  cells stimulated  to clonal expansion by 
mitogens. These supernatants  did not  increase the average B cell clone size. Similar 
activity was found in Con A and MLR supernatants with no detectable IL-2. These 
experiments provided unequivocal  proof that  some monoclonally and  polyclonally 
derived T  cell products act directly on B lymphocytes. 
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Materials  and Methods 
Mice.  BDF1 (C57BL/6 ×  DBA/2)F1 male and female mice, 2-4 mo old, were bred in our 
colony at the University of California, San Diego. 
Mitogens.  Escherichia  coli 0127:B8 lipopolysaceharide (LPS) was obtained from Difco Labo- 
ratories  (Detroit, MI). Dextran sulfate (DXS) was obtained from Gibco Laboratories (Grand 
Island Biological Co., Grand Island, NY) as a sodium salt,  17% sulfur, 500,000  mol wt. 
Lymphocyte Cultures.  Spleen cells from mice injected with 0.06 ml rabbit ATS (Microbiolog- 
ical  Associates,  Walkersville,  MD)  48  h  before  killing  were  treated  with  anti-Thy-l.2  plus 
complement as described previously (10). LPS and DXS were used at final concentrations of 25 
and 20 pg/ml, respectively. The visual assay of clonal proliferation is described elsewhere (13). 
DL-TRF.  Supernatants  from C.C3.11.75 stimulated with anti-Thy-l.2 and mitomycin C- 
treated BALB.K spleen cells for 24 h were prepared as described elsewhere (10). 
Data Analysis.  A minimum of two cell inputs (cells per well) with at least  120 cultures/point 
were  used  for  each  experimental  condition  tested.  Poisson  analyses  were  performed,  and 
frequencies of responding cells, i.e., cells induced to clonal expansion, were calculated according 
to  the  weighted  mean  method  described  by  Taswell  (14). 95%  confidence  intervals  were 
calculated for each frequency reported and are included in the data. Differences between two 
frequencies are significant at the 0.05 level when the confidence intervals do not overlap. 
Results 
(DL)TRF  Increases  B  Cell  Clonal Expansion.  T  cell-depleted  spleen  cells  were 
cultured  at limiting dilutions with LPS and DXS.  Under optimal conditions,  ~80% 
of input B cells yield clones 4 d later, and cultures receiving a single input cell exhibit 
clonal expansion  (13). The absolute magnitude of the B cell growth response depends 
on  the  batch  of fetal  bovine  serum  (FBS)  used  (13,  15,  16).  FBS  with  suboptimal 
growth  support  was  chosen  to  examine  effects  of T  cell  products  on  clonal  B  cell 
growth. Medium or (DL)TRF supernatant were diluted in BSS and added to culture. 
The  results  of several  experiments  are  given  in  Table  I.  In  every  experiment,  the 
presence of monoclonal T  cell-derived  mediator significantly increased clonal B cell 
growth. The proportion of input B cells stimulated to clonal expansion was increased 
up to about sevenfold by the presence of supernatants  containing (DL)TRF. 
Monoclonal and Polyclonal Sources of TRF Increase B Cell Clonal Expansion.  Monoclonal 
(DL)TRF was compared to two other standard sources of TRF activity, Con A, and 
MLR  supernatants.  Con A  and  MLR  TRF were harvested  after 4  d  of culture and 
were devoid of IL-2 by the T  cell growth factor assay (data not shown). Comparison 
of these sources of TRF with (DL)TRF for clonal T  cell growth enhancement is shown 
in  Table  II. All  sources  of TRF  increased  clonal  B  cell  growth  at  the  appropriate 
concentration. These results confirm that B cell growth-enhancing activity is found in 
TRF preparations  from both a  monoclonal T  cell line and normal splenic T  cells. 
(DL) TRF Acts Directly on Single B Cells.  The experiments described in the previous 
sections were performed  at  input  cell  numbers  0.8-4 cells per culture.  This leaves a 
remote possibility that  (DL)TRF exerted  its B cell clonal growth-promoting activity 
indirectly by acting on rare T  cells that had escaped treatment  with ATS and anti- 
Thy-1.2 plus complement. If these cells were present at the level of 1%, then < 1 of 25 
cultures  should have contained  a  T  cell,  and  this  level of contamination  would not 
significantly affect the frequencies of B cell clonal precursors shown. Nevertheless,  it 
seemed worthwhile to provide a  formal proof. Cultures were initiated,  and wells were 
examined to determine those that received a single input cell; these were marked and 
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TABLE  I 
(DL) TRF Enhancement of B Cell Clonal Expansion 
Experiment 
Percent input cells yielding B cell clones 
1% (vol/vol) (DL)TRF  Control  supernalanl 
1  7.8 +  2.5*  57.5 --  14.0:~ 
2  16.2 -  4.8  46.5 +  10.5~z 
3  9.5 +  3.1)  47.0 +_ 5.5~: 
4  10.0 +  3.5  26.3 +- 6.3~: 
5  13.5 +  4.5  63.2 +  13.2:]: 
Limiting dilution analyses of T  cell-depleted spleen cells induced to clonal 
expansion by LPS +  DXS. Cultures received 1% (vol/vol) medium (control) 
or (DL)TRF supernatant at culture initiation. 
* Frequency of responding cells and 95'7~ confidence interval determined from 
a minimum of 240 cultures. 
:~ Significantly different from control; P <  0.05. 
TABLE  II 
Comparison of (DL) TRF with Con A and MLR TRF Supernatants Devoid of lL-2 
Percent 
(vol/vol) 
Percent input cells yielding B cell 
clones 
4-d C57B1/6  C.C3.11.75 
anti-DBA/2  anti-BALB.K 
supernatant  supernatant 
Percent 
vol/vol) 
Percent input cells yielding B cell 
clones 
C.C3.11.75  4-day Con A  anti-BALB.K  supernatant  supernatant 
0  16.4 --- 5.0  16.4 +  5.0  0  29,0 -----  8.5  29.0 +  8.5 
8.5  14.8 +  5.2  47.5 +  10.5"  4  39.0 +  10.5  -- 
1.7  40,5 +  9.5*  30.5 +  7.5*  1  57.0 -+ 14.0"  -- 
0.3  23.5 +  7.0  28.8 +  7.5  0.25  31,5 +_ 9.0  65.0 ±  17.5" 
0.06  --  47.0 +  12.5 
Frequencies of input cells yielding B cell clones are given with 95% confidence intervals. MLR and Con 
A supernatants were harvested on day 4 and were devoid of IL-2,  presumably due to exhaustion by T 
cells. (DL)TRF supernatant was harvested on day  1 and was devoid of IL-2. 
* Significantly different from control; P <  0.05. 
cell  clones.  This  was  compared  with  the  frequency  of cultures  with  one  initial  cell 
yielding B  cell clones. The  results are presented  in Table  III. The  frequency of single 
cell  (DL)TRF  cultures stimulated  to clonal expansion  was not significantly different 
from that calculated by limiting dilution analysis. This confirmed  the previous results 
and provided unequivocal  evidence that  (DL)TRF  did not act through  accessory cells 
to enhance  B  cell growth. 
(DL) TRF Does Not Increase Average  B  Cell Clone Sizes.  It  is  possible  that  growth- 
promoting  activities  in  (DL)TRF  could  act  to  increase  the  clone  size  of  B  cells 
stimulated  to  grow.  This  was  tested  by  calculating  average  B  cell  clone sizes  in  the 
presence and  absence of (DL)TRF.  These  are shown  in Table  IV. The  total number 
of clones was calculated  and  divided  into the total number  of cells in all wells on day 
4.  Average  mitogen-induced  B  cell  clone  sizes  were  comparable  whether  or  not 
(DL)TRF  was present. This suggests that average rates of entry into cycle and division 
were  similar  in  the  presence  and  absence  of  (DL)TRF.  Experiments  with  purified 
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TABLE  III 
(DL) TRF Acts on Single B Cells 
Experiment  Addit ions  Average input/ 
well 
Percent  input cells yielding B cell clones 
Poisson analysis of  Cultures with only one 
all cultures  input cell 
1  Medium  0.8  8.7 ±  3.3  -- 
1% (DL)TRF  0.8  24.2 -+ 7.0*  28.1 (41/146)~: 
2  Medium  3.0  9.9 +  3.5  -- 
1% (DL)TRF  3.0  26.7 ±  6.7*  27.5 (65/236) 
* Significantly different from control; P <  0.05. 
"~ Numbers in parentheses indicate the number of wells with one input cell positive  for growth over tile 
total number of wells receiving one input cell. 
TABLE IV 
B Cell Clone Size Analyses in the Presence and Absence of (DL)TRF 
Percent  input cells  Average clone size 
Experiment  Additions  yielding B cell clones 
-  95'7, CI*  (95% CI) 
l  Medium  7.7 _+ 2.6  7.6 (5.7-11.5) 
1% (DL)TRF  57.6 ±  14.0~:  7.8 (6.3 10.4) 
2  Medium  16.3 ± 4.7  7.1 (5.5-9.9) 
1% (DL)TRF  46.6 ±  10.4~:  8.5 (7.0-11.0) 
3  Medium  9.4 ±  3.4  7.5 (5.5-11.8) 
1% (DL)TRF  47.0 ±  10.5~:  9.1  (7.4-I 1.7) 
4  Medium  1'3.5 +  4.7  9.3 (6.9 14.2) 
1% (DL)TRF  63.3 ±  14.1,  7.2 (5.9 9.3) 
5  Medium  9.9 ±  3.5  7.7 (5.6-11.9) 
1% (DL)TRF  26.7 +  6.7~:  7.1  (5.7-9.5) 
* 95% confidence interval. 
Significantly different from control; P <  0.05. 
activity of (DL)TRF  appeared  to  act  by  increasing  the  number  of precursors  that 
undergo clonal expansion  rather  than  by altering the kinetics of proliferation. 
Discussion 
We have demonstrated  that a  factor (or factors) present in supernatant of stimulated 
cultures of an alloreactive T  cell line can act directly on a  single B  cell in the absence 
of any other cell type. The effect of this factor (or factors)  is to increase the frequency 
of B  cells  that  proliferate  in  response  to  LPS  and  DXS.  The  average  clone  size  of 
responding  B  cells  is  not  altered  by  the  presence  of the  culture  supernatants.  This 
provides clear and unequivocal proof of the direct action of a  T  cell factor on a  target 
B  cell. 
Several points can be made regarding the significance of this observation.  First, the 
same  supernatants  of this  T  cell  line  contain  an  activity,  designated  as  (DL)TRF, 
which, in synergy with IL-2, restores the plaque-forming response ofT-depleted  spleen 
cells to SRBC  (t0).  They  also  promote  immunoglobulin  secretion  in  cultures  where 
most  cells were  from  the  B  cell  tumor,  BCLi (17).  The  activity  in  the  single  B  cell 
assay is to increase the frequency of B  cells that  proliferate. It is possible that the same 
factor  is  active  in  all  three  assays,  but  we  have  no  evidence  as  yet  to  prove  this. 310  WETZEL ET AL.  BRIEF  DEFINITIVE REPORT 
Although (DL)TRF supernatants can contain interferon (J. Yamamoto, unpublished 
observations),  they are devoid of both IL-1 and IL-2 (10).  Purification and isolation 
of the factors should clarify whether a single entity can mediate these three activities. 
Whether  the  growth enhancement  of (DL)TRF reported  here  represents  a  signal 
that  also  takes  place  in  responses  to  antigen  is  not  known.  Results  from  another 
laboratory (18) suggest, however, that this is the case. 
We  report  only  the  effect  of culture  supernatants  of the, T  cell  line  C.C3.11.75 
containing (DL)TRF. We have reason to believe there may be several different factors 
with different roles that constitute nonspecific TRF activity. Other laboratories have 
also shown a  role for a  variety of factors in B cell proliferation  and immunoglobulin 
secretion  (19,  20).  There  is  as  yet  too  little  information  to  determine  how  these 
activities can be related  to one another and to the activity described here.  It will be 
necessary  to  test  each  of these  in  assay  systems  that  measure  response  initiation, 
proliferation,  and secretion at the single cell level. 
Summary 
We have used a  B cell cloning system in which the response of a  single isolated  B 
cell to lipopolysaccharide and dextran sulfide can be followed. We have shown that 
culture supernatants  from the Dennert  long-term alloreactive T  cell line C.C3.11.75 
increase  the frequency of B cells stimulated  to clonal expansion by mitogens. These 
culture supernatants are devoid ofinterleukin  1 and 2 but contain the T  cell-replacing 
factor activity (DL)TRF. These experiments provide unequivocal proof that a T  cell- 
derived  factor or factors can  act  directly on a  B  lymphocyte in  the  absence of any 
other cell. 
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